BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ohashi S, Miyamoto S, Kikuchi O, Goto T, Amanuma Y, Muto M. Recent Advances From Basic and Clinical Studies of Esophageal Squamous Cell Carcinoma. Gastroenterology. 2015;149:1700-1715. [PMID: 26376349 DOI: 10.1053/j.gastro.2015.08.054] [Cited by in Crossref: 243] [Cited by in F6Publishing: 257] [Article Influence: 34.7] [Reference Citation Analysis]
Number Citing Articles
1 Lu Z, Zhang G, Zhang Y, Hua P, Fang M, Wu M, Liu T. Isoalantolactone induces apoptosis through reactive oxygen species-dependent upregulation of death receptor 5 in human esophageal cancer cells. Toxicology and Applied Pharmacology 2018;352:46-58. [DOI: 10.1016/j.taap.2018.05.026] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
2 Yu J, Wu X, Huang K, Zhu M, Zhang X, Zhang Y, Chen S, Xu X, Zhang Q. Bioinformatics identification of lncRNA biomarkers associated with the progression of esophageal squamous cell carcinoma. Mol Med Rep. 2019;19:5309-5320. [PMID: 31059058 DOI: 10.3892/mmr.2019.10213] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
3 Aguilar LE, Ghavaminejad A, Park CH, Kim CS. On-demand drug release and hyperthermia therapy applications of thermoresponsive poly-(NIPAAm-co-HMAAm)/polyurethane core-shell nanofiber mat on non-vascular nitinol stents. Nanomedicine: Nanotechnology, Biology and Medicine 2017;13:527-38. [DOI: 10.1016/j.nano.2016.12.012] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
4 Wei L, Wang B, Hu L, Xu Y, Li Z, Shen Y, Huang H. MEX3A is upregulated in esophageal squamous cell carcinoma (ESCC) and promotes development and progression of ESCC through targeting CDK6. Aging (Albany NY) 2020;12:21091-113. [PMID: 33188661 DOI: 10.18632/aging.103196] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
5 Ma XL, Yao H, Wang X, Wei Y, Cao LY, Zhang Q, Zhang L. ILK predicts the efficacy of chemoradiotherapy and the prognosis of patients with esophageal squamous cell carcinoma. Oncol Lett 2019;18:4114-25. [PMID: 31579417 DOI: 10.3892/ol.2019.10768] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Vartolomei MD, Iwata T, Roth B, Kimura S, Mathieu R, Ferro M, Shariat SF, Seitz C. Impact of alcohol consumption on the risk of developing bladder cancer: a systematic review and meta-analysis. World J Urol 2019;37:2313-24. [PMID: 31172281 DOI: 10.1007/s00345-019-02825-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
7 Xiao Y, Su M, Ou W, Wang H, Tian B, Ma J, Tang J, Wu J, Wu Z, Wang W, Zhou Y. Involvement of noncoding RNAs in epigenetic modifications of esophageal cancer. Biomed Pharmacother 2019;117:109192. [PMID: 31387188 DOI: 10.1016/j.biopha.2019.109192] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
8 Wang L, Wang X, Yan P, Liu Y, Jiang X. LINC00261 Suppresses Cisplatin Resistance of Esophageal Squamous Cell Carcinoma Through miR-545-3p/MT1M Axis. Front Cell Dev Biol 2021;9:687788. [PMID: 34336838 DOI: 10.3389/fcell.2021.687788] [Reference Citation Analysis]
9 Chen Y, Wang J, Zhou H, Huang Z, Qian L, Shi W. Identification of Prognostic Risk Model Based on DNA Methylation-Driven Genes in Esophageal Adenocarcinoma. Biomed Res Int 2021;2021:6628391. [PMID: 34222478 DOI: 10.1155/2021/6628391] [Reference Citation Analysis]
10 Weng NQ, Chi J, Wen J, Mai SJ, Zhang MY, Huang L, Liu J, Yang XZ, Xu GL, Fu JH, Wang HY. The prognostic value of a seven-lncRNA signature in patients with esophageal squamous cell carcinoma: a lncRNA expression analysis. J Transl Med 2020;18:47. [PMID: 32005248 DOI: 10.1186/s12967-020-02224-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
11 Kwak AW, Cho SS, Yoon G, Oh HN, Lee MH, Chae JI, Shim JH. Licochalcone H Synthesized by Modifying Structure of Licochalcone C Extracted from Glycyrrhiza inflata Induces Apoptosis of Esophageal Squamous Cell Carcinoma Cells. Cell Biochem Biophys 2020;78:65-76. [PMID: 31707583 DOI: 10.1007/s12013-019-00892-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
12 Luebeck GE, Vaughan TL, Curtius K, Hazelton WD. Modeling historic incidence trends implies early field cancerization in esophageal squamous cell carcinoma. PLoS Comput Biol 2021;17:e1008961. [PMID: 33939693 DOI: 10.1371/journal.pcbi.1008961] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Huang B, Zhong N, Xia L, Yu G, Cao H. Sparse Representation-Based Patient-Specific Diagnosis and Treatment for Esophageal Squamous Cell Carcinoma. Bull Math Biol 2018;80:2124-36. [PMID: 29869044 DOI: 10.1007/s11538-018-0449-8] [Reference Citation Analysis]
14 Odera JO, Xiong Z, Huang C, Gu N, Yang W, Githang'a J, Odera E, Paiboonrungruang C, Chen X. NRF2/ACSS2 axis mediates the metabolic effect of alcohol drinking on esophageal squamous cell carcinoma. Biochem J 2020;477:3075-89. [PMID: 32776152 DOI: 10.1042/BCJ20200452] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
15 Tu Q, Gong H, Yuan C, Liu G, Huang J, Li Z, Luo J. Δ133p53/FLp53 Predicts Poor Clinical Outcome in Esophageal Squamous Cell Carcinoma. Cancer Manag Res 2020;12:7405-17. [PMID: 32884352 DOI: 10.2147/CMAR.S263559] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Yuan Q, Sun N, Meng Z, Chen X. Pulmonary papillary squamous cell carcinoma: a population-based analysis of incidence, treatment, and prognosis. J Thorac Dis 2019;11:4271-81. [PMID: 31737312 DOI: 10.21037/jtd.2019.09.71] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Chen Q, Li J, Yang X, Ma J, Gong F, Liu Y. Prdx1 promotes the loss of primary cilia in esophageal squamous cell carcinoma. BMC Cancer 2020;20:372. [PMID: 32357862 DOI: 10.1186/s12885-020-06898-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Shi H, Yu F, Mao Y, Ju Q, Wu Y, Bai W, Wang P, Xu R, Jiang M, Shi J. EphA2 chimeric antigen receptor-modified T cells for the immunotherapy of esophageal squamous cell carcinoma. J Thorac Dis 2018;10:2779-88. [PMID: 29997940 DOI: 10.21037/jtd.2018.04.91] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
19 Osako Y, Seki N, Kita Y, Yonemori K, Koshizuka K, Kurozumi A, Omoto I, Sasaki K, Uchikado Y, Kurahara H, Maemura K, Natsugoe S. Regulation of MMP13 by antitumor microRNA-375 markedly inhibits cancer cell migration and invasion in esophageal squamous cell carcinoma. Int J Oncol. 2016;49:2255-2264. [PMID: 27779648 DOI: 10.3892/ijo.2016.3745] [Cited by in Crossref: 41] [Cited by in F6Publishing: 44] [Article Influence: 6.8] [Reference Citation Analysis]
20 Pan Q, Li B, Zhang J, Du X, Gu D. LncRNA THAP9-AS1 accelerates cell growth of esophageal squamous cell carcinoma through sponging miR-335-5p to regulate SGMS2. Pathol Res Pract 2021;224:153526. [PMID: 34273804 DOI: 10.1016/j.prp.2021.153526] [Reference Citation Analysis]
21 Su M, Tang J, Zhang B, Yang D, Wu Z, Wu J, Zhou Y, Liao Q, Wang H, Wang W, Xiao Y. LncRNA GACAT3 promotes esophageal squamous cell carcinoma progression through regulation of miR-149/FOXM1. Cancer Cell Int 2021;21:478. [PMID: 34496842 DOI: 10.1186/s12935-021-02192-4] [Reference Citation Analysis]
22 Jia W, Wang W, Ji CS, Niu JY, Lv YJ, Zhou HC, Hu B. Coexpression of periostin and EGFR in patients with esophageal squamous cell carcinoma and their prognostic significance. Onco Targets Ther 2016;9:5133-42. [PMID: 27574454 DOI: 10.2147/OTT.S111132] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
23 Zhang Y, Xiao G, Wang R. Clinical significance of systemic immune-inflammation index (SII) and C-reactive protein-to-albumin ratio (CAR) in patients with esophageal cancer: a meta-analysis. Cancer Manag Res 2019;11:4185-200. [PMID: 31190988 DOI: 10.2147/CMAR.S190006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
24 Cao YY, Yu J, Liu TT, Yang KX, Yang LY, Chen Q, Shi F, Hao JJ, Cai Y, Wang MR, Lu WH, Zhang Y. Plumbagin inhibits the proliferation and survival of esophageal cancer cells by blocking STAT3-PLK1-AKT signaling. Cell Death Dis 2018;9:17. [PMID: 29339720 DOI: 10.1038/s41419-017-0068-6] [Cited by in Crossref: 45] [Cited by in F6Publishing: 37] [Article Influence: 11.3] [Reference Citation Analysis]
25 Shahin MI, Roy J, Hanafi M, Wang D, Luesakul U, Chai Y, Muangsin N, Lasheen DS, Abou El Ella DA, Abouzid KA, Neamati N. Synthesis and biological evaluation of novel 2-oxo-1,2-dihydroquinoline-4-carboxamide derivatives for the treatment of esophageal squamous cell carcinoma. Eur J Med Chem 2018;155:516-30. [PMID: 29908444 DOI: 10.1016/j.ejmech.2018.05.042] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
26 Onochi K, Shiga H, Takahashi S, Watanabe N, Fukuda S, Ishioka M, Koizumi S, Matsuhasi T, Jin M, Iijima K. Risk Factors Linking Esophageal Squamous Cell Carcinoma With Head and Neck Cancer or Gastric Cancer. Journal of Clinical Gastroenterology 2019;53:e164-70. [DOI: 10.1097/mcg.0000000000001019] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
27 Chen B, Yang H, Ma H, Li Q, Qiu B, Hu Y, Zhu Y. Radiotherapy for small cell carcinoma of the esophagus: outcomes and prognostic factors from a retrospective study. Radiat Oncol. 2019;14:210. [PMID: 31752922 DOI: 10.1186/s13014-019-1415-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
28 Baba Y, Yoshida N, Kinoshita K, Iwatsuki M, Yamashita YI, Chikamoto A, Watanabe M, Baba H. Clinical and Prognostic Features of Patients With Esophageal Cancer and Multiple Primary Cancers: A Retrospective Single-institution Study. Ann Surg 2018;267:478-83. [PMID: 28151796 DOI: 10.1097/SLA.0000000000002118] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
29 Shi Y, Fang N, Li Y, Guo Z, Jiang W, He Y, Ma Z, Chen Y. Circular RNA LPAR3 sponges microRNA-198 to facilitate esophageal cancer migration, invasion, and metastasis. Cancer Sci 2020;111:2824-36. [PMID: 32495982 DOI: 10.1111/cas.14511] [Cited by in Crossref: 10] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
30 Jiang M, Zhu Y, Yu H. Ginsenoside 20(S)-Rg3 suppresses cell viability in esophageal squamous cell carcinoma via modulating miR-324-5p-targeted PSME3. Hum Exp Toxicol 2021;:9603271211017311. [PMID: 34002647 DOI: 10.1177/09603271211017311] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Liu T, Du LT, Wang YS, Gao SY, Li J, Li PL, Sun ZW, Binang H, Wang CX. Development of a Novel Serum Exosomal MicroRNA Nomogram for the Preoperative Prediction of Lymph Node Metastasis in Esophageal Squamous Cell Carcinoma. Front Oncol 2020;10:573501. [PMID: 33123480 DOI: 10.3389/fonc.2020.573501] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
32 Chu J, Niu X, Chang J, Shao M, Peng L, Xi Y, Lin A, Wang C, Cui Q, Luo Y, Fan W, Chen Y, Sun Y, Guo W, Tan W, Lin D, Wu C. Metabolic remodeling by TIGAR overexpression is a therapeutic target in esophageal squamous-cell carcinoma. Theranostics 2020;10:3488-502. [PMID: 32206103 DOI: 10.7150/thno.41427] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
33 Zhao RH, Zhu CH, Li XK, Cao W, Zong H, Cao XG, Hu HY. BC200 LncRNA a potential predictive marker of poor prognosis in esophageal squamous cell carcinoma patients. Onco Targets Ther 2016;9:2221-6. [PMID: 27143917 DOI: 10.2147/OTT.S99401] [Cited by in Crossref: 6] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
34 Jin F, Zhu Y, Chen J, Wang R, Wang Y, Wu Y, Zhou P, Song X, Ren Z, Dong J. BRE Promotes Esophageal Squamous Cell Carcinoma Growth by Activating AKT Signaling. Front Oncol 2020;10:1407. [PMID: 32850455 DOI: 10.3389/fonc.2020.01407] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
35 Wang M, An S, Wang D, Ji H, Geng M, Guo X, Wang Z. Quantitative Proteomics Identify the Possible Tumor Suppressive Role of Protease-Activated Receptor-4 in Esophageal Squamous Cell Carcinoma Cells. Pathol Oncol Res 2019;25:937-43. [PMID: 29502225 DOI: 10.1007/s12253-018-0395-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
36 Wang X, Xiao Y, Huang M, Shen B, Xue H, Wu K. Effect of TRPM2-Mediated Calcium Signaling on Cell Proliferation and Apoptosis in Esophageal Squamous Cell Carcinoma. Technol Cancer Res Treat 2021;20:15330338211045213. [PMID: 34605693 DOI: 10.1177/15330338211045213] [Reference Citation Analysis]
37 Jesinghaus M, Boxberg M, Konukiewitz B, Slotta-Huspenina J, Schlitter AM, Steiger K, Specht K, Wieczorek K, Warth A, Schmidt T, Hartmann A, Demir IE, Feith M, Ott K, Weichert W. A Novel Grading System Based on Tumor Budding and Cell Nest Size Is a Strong Predictor of Patient Outcome in Esophageal Squamous Cell Carcinoma. Am J Surg Pathol 2017;41:1112-20. [PMID: 28505009 DOI: 10.1097/PAS.0000000000000865] [Cited by in Crossref: 25] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
38 Chen Z, Huang X, Gao Y, Zeng S, Mao W. Plasma-metabolite-based machine learning is a promising diagnostic approach for esophageal squamous cell carcinoma investigation. J Pharm Anal 2021;11:505-14. [PMID: 34513127 DOI: 10.1016/j.jpha.2020.11.009] [Reference Citation Analysis]
39 Hoshino I, Ishige F, Iwatate Y, Gunji H, Kuwayama N, Nabeya Y, Yokota H, Takeshita N, Iida K, Nagase H, Matsubara H. Cell-free microRNA-1246 in different body fluids as a diagnostic biomarker for esophageal squamous cell carcinoma. PLoS One 2021;16:e0248016. [PMID: 33690683 DOI: 10.1371/journal.pone.0248016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Zhang N, Zhang SW. Long-term effects of radiation prior to surgery and chemotherapy on survival of esophageal cancer undergoing surgery. Medicine (Baltimore) 2019;98:e17617. [PMID: 31651875 DOI: 10.1097/MD.0000000000017617] [Reference Citation Analysis]
41 Shao M, Li W, Wang S, Liu Z. Identification of key genes and pathways associated with esophageal squamous cell carcinoma development based on weighted gene correlation network analysis. J Cancer 2020;11:1393-402. [PMID: 32047546 DOI: 10.7150/jca.30699] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
42 Shinno N, Kimura H, Sada R, Takiguchi S, Mori M, Fumoto K, Doki Y, Kikuchi A. Activation of the Dickkopf1-CKAP4 pathway is associated with poor prognosis of esophageal cancer and anti-CKAP4 antibody may be a new therapeutic drug. Oncogene 2018;37:3471-84. [PMID: 29563607 DOI: 10.1038/s41388-018-0179-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
43 Suo D, Wang Z, Li L, Chen Q, Zeng T, Liu R, Yun J, Guan XY, Li Y. HOXC10 upregulation confers resistance to chemoradiotherapy in ESCC tumor cells and predicts poor prognosis. Oncogene 2020;39:5441-54. [PMID: 32587398 DOI: 10.1038/s41388-020-1375-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
44 Zhao X, Ren Y, Hu Y, Cui N, Wang X, Cui Y. Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the esophagus or the gastroesophageal junction: A meta-analysis based on clinical trials. PLoS One 2018;13:e0202185. [PMID: 30138325 DOI: 10.1371/journal.pone.0202185] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 5.5] [Reference Citation Analysis]
45 Huang TX, Fu L. The immune landscape of esophageal cancer. Cancer Commun (Lond) 2019;39:79. [PMID: 31771653 DOI: 10.1186/s40880-019-0427-z] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 11.7] [Reference Citation Analysis]
46 Zhu Q, Huang L, Yang Q, Ao Z, Yang R, Krzesniak J, Lou D, Hu L, Dai X, Guo F, Liu F. Metabolomic analysis of exosomal-markers in esophageal squamous cell carcinoma. Nanoscale 2021;13:16457-64. [PMID: 34648610 DOI: 10.1039/d1nr04015d] [Reference Citation Analysis]
47 Li Y, Zhao W, Ni J, Zou L, Yang X, Yu W, Fu X, Zhao K, Zhang Y, Chen H, Xiang J, Xie C, Zhu Z. Predicting the Value of Adjuvant Therapy in Esophageal Squamous Cell Carcinoma by Combining the Total Number of Examined Lymph Nodes with the Positive Lymph Node Ratio. Ann Surg Oncol 2019;26:2367-74. [PMID: 31187360 DOI: 10.1245/s10434-019-07489-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
48 Luo Q, Wu X, Zhao P, Nan Y, Chang W, Zhu X, Su D, Liu Z. OTUD1 Activates Caspase-Independent and Caspase-Dependent Apoptosis by Promoting AIF Nuclear Translocation and MCL1 Degradation. Adv Sci (Weinh) 2021;8:2002874. [PMID: 33898171 DOI: 10.1002/advs.202002874] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Wang J, Zhang Z, Che Y, Yuan Z, Lu Z, Li Y, Wan J, Sun H, Chen Z, Pu J, He J. Rabdocoestin B exhibits antitumor activity by inducing G2/M phase arrest and apoptosis in esophageal squamous cell carcinoma. Cancer Chemother Pharmacol 2018;81:469-81. [PMID: 29308536 DOI: 10.1007/s00280-017-3507-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
50 Kim EJ, Kim JH, Song HJ, Park SR, Kim YH, Kim HR, Kim SB. Impact of sequential lines of palliative chemotherapy in patients with recurrent/metastatic esophageal squamous cell carcinoma: A retrospective analysis of 107 patients at a single center. Asia Pac J Clin Oncol 2020;16:e53-62. [PMID: 31657877 DOI: 10.1111/ajco.13283] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
51 Xu J, Wang J, Liu L, Chen L, Hu S, Liu F. MicroRNA -196b is related to the overall survival of patients with esophageal squamous cell carcinoma and facilitates tumor progression by regulating SOCS2 (Suppressor Of Cytokine Signaling 2). Bioengineered 2021;12:7737-46. [PMID: 34605350 DOI: 10.1080/21655979.2021.1982329] [Reference Citation Analysis]
52 Niu C, Liu Y, Wang J, Liu Y, Zhang S, Zhang Y, Zhang L, Zhao D, Liu F, Chao L, Wang X, Zhang C, Song G, Zhang Z, Li Y, Yan Z, Wen Y, Ge Y, Zang Z, Feng W, Zhang H, Tao L, Nakyeyune R, Shen Y, Shao Y, Guo X, Miles T, Yang A, Liu F, Wang G. Risk factors for esophageal squamous cell carcinoma and its histological precursor lesions in China: a multicenter cross-sectional study. BMC Cancer 2021;21:1034. [PMID: 34530751 DOI: 10.1186/s12885-021-08764-x] [Reference Citation Analysis]
53 Zhang Q, Guan F, Fan T, Li S, Ma S, Zhang Y, Guo W, Liu H. LncRNA WDFY3-AS2 suppresses proliferation and invasion in oesophageal squamous cell carcinoma by regulating miR-2355-5p/SOCS2 axis. J Cell Mol Med 2020;24:8206-20. [PMID: 32536038 DOI: 10.1111/jcmm.15488] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
54 Zhu H, Song H, Chen G, Yang X, Liu J, Ge Y, Lu J, Qin Q, Zhang C, Xu L, Di X, Cai J, Ma J, Zhang S, Sun X. eEF2K promotes progression and radioresistance of esophageal squamous cell carcinoma. Radiother Oncol 2017;124:439-47. [PMID: 28431753 DOI: 10.1016/j.radonc.2017.04.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
55 Qin B, Dong M, Wang Z, Wan J, Xie Y, Jiao Y, Yan D. Long non‑coding RNA CASC15 facilitates esophageal squamous cell carcinoma tumorigenesis via decreasing SIM2 stability via FTO‑mediated demethylation. Oncol Rep 2021;45:1059-71. [PMID: 33650646 DOI: 10.3892/or.2020.7917] [Reference Citation Analysis]
56 Hamai Y, Hihara J, Emi M, Furukawa T, Murakami Y, Nishibuchi I, Ibuki Y, Yamakita I, Kurokawa T, Nagata Y, Okada M. Evaluation of Prognostic Factors for Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemoradiotherapy Followed by Surgery. World J Surg 2018;42:1496-505. [PMID: 29030675 DOI: 10.1007/s00268-017-4283-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
57 Gao Y, Zhu Y, Xu X, Wang F, Shen W, Leng X, Zhao J, Liu B, Wang Y, Liu P. Surface PEGylated Cancer Cell Membrane-Coated Nanoparticles for Codelivery of Curcumin and Doxorubicin for the Treatment of Multidrug Resistant Esophageal Carcinoma. Front Cell Dev Biol 2021;9:688070. [PMID: 34386493 DOI: 10.3389/fcell.2021.688070] [Reference Citation Analysis]
58 Nishimura J, Tanaka H, Yamakoshi Y, Hiramatsu S, Tamura T, Toyokawa T, Muguruma K, Maeda K, Hirakawa K, Ohira M. Impact of tumor-infiltrating LAMP-3 dendritic cells on the prognosis of esophageal squamous cell carcinoma. Esophagus 2019;16:333-44. [PMID: 30968254 DOI: 10.1007/s10388-019-00669-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
59 Sasaki F, Kanmura S, Oda K, Maeda H, Kabayama M, Iwaya H, Komaki Y, Arima S, Tanoue S, Hashimoto S, Fujita H, Ido A. Acetaldehyde breath test as a cancer risk marker in patients with esophageal and hypopharyngeal squamous cell carcinoma. PLoS One 2021;16:e0251457. [PMID: 34010294 DOI: 10.1371/journal.pone.0251457] [Reference Citation Analysis]
60 Wang M, Zhang S, Sun Q, Yang X, Wang Y, Shang R, Zhu Y, Yao H, Li Y. Dual effects of an anti-CD147 antibody for Esophageal cancer therapy. Cancer Biol Ther 2019;20:1443-52. [PMID: 31411555 DOI: 10.1080/15384047.2019.1647052] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
61 Li Z, Zhou Y, Tu B, Bu Y, Liu A, Kong J. Long noncoding RNA MALAT1 affects the efficacy of radiotherapy for esophageal squamous cell carcinoma by regulating Cks1 expression. J Oral Pathol Med 2017;46:583-90. [PMID: 27935117 DOI: 10.1111/jop.12538] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 5.0] [Reference Citation Analysis]
62 Saito T, Ohashi S, Mizumoto A, Muto M. Patient-derived tumor models of esophageal cancer. Enzymes 2019;46:97-111. [PMID: 31727279 DOI: 10.1016/bs.enz.2019.10.003] [Reference Citation Analysis]
63 Mizumoto A, Ohashi S, Kamada M, Saito T, Nakai Y, Baba K, Hirohashi K, Mitani Y, Kikuchi O, Matsubara J, Yamada A, Takahashi T, Lee H, Okuno Y, Kanai M, Muto M. Combination treatment with highly bioavailable curcumin and NQO1 inhibitor exhibits potent antitumor effects on esophageal squamous cell carcinoma. J Gastroenterol 2019;54:687-98. [PMID: 30737573 DOI: 10.1007/s00535-019-01549-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
64 Osako Y, Seki N, Koshizuka K, Okato A, Idichi T, Arai T, Omoto I, Sasaki K, Uchikado Y, Kita Y, Kurahara H, Maemura K, Natsugoe S. Regulation of SPOCK1 by dual strands of pre-miR-150 inhibit cancer cell migration and invasion in esophageal squamous cell carcinoma. J Hum Genet 2017;62:935-44. [PMID: 28659612 DOI: 10.1038/jhg.2017.69] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
65 Nair DV, Reddy AG. Laboratory animal models for esophageal cancer. Vet World 2016;9:1229-32. [PMID: 27956773 DOI: 10.14202/vetworld.2016.1229-1232] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
66 Lin Q, Mao W, Wu Q, He X, Li S, Fan Y, Chen J, Feng T, Cao X. Downregulation of KLK13 promotes the invasiveness and metastasis of oesophageal squamous cell carcinoma. Biomed Pharmacother 2017;96:1008-15. [PMID: 29221724 DOI: 10.1016/j.biopha.2017.11.129] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
67 Zhang X, Fan T, Li S, Guan F, Zhang J, Liu H. C-Phycocyanin elicited antitumor efficacy via cell-cycle arrest, apoptosis induction, and invasion inhibition in esophageal squamous cell carcinoma. J Recept Signal Transduct Res 2019;39:114-21. [PMID: 31322033 DOI: 10.1080/10799893.2019.1638400] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
68 Gu YM, Yang YS, Hu WP, Wang WP, Yuan Y, Chen LQ. Prognostic value of lymphovascular invasion in patients with esophageal squamous cell carcinoma. Ann Transl Med 2019;7:256. [PMID: 31355223 DOI: 10.21037/atm.2019.05.23] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
69 Grubic AD, Ayazi S, Zaidi AH, Schwameis K, Jobe BA. Esophageal Squamous Cell Carcinoma After Radiofrequency Catheter Ablation Thermal Injury. Ann Thorac Surg 2021;111:e185-7. [PMID: 32853572 DOI: 10.1016/j.athoracsur.2020.06.050] [Reference Citation Analysis]
70 Khan T, Relitti N, Brindisi M, Magnano S, Zisterer D, Gemma S, Butini S, Campiani G. Autophagy modulators for the treatment of oral and esophageal squamous cell carcinomas. Med Res Rev 2020;40:1002-60. [PMID: 31742748 DOI: 10.1002/med.21646] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
71 Deng L, Zhu X, Yu Z, Li Y, Qin L, Liu Z, Feng L, Guo R, Zheng Y. Novel T7-Modified pH-Responsive Targeted Nanosystem for Co-Delivery of Docetaxel and Curcumin in the Treatment of Esophageal Cancer. Int J Nanomedicine 2020;15:7745-62. [PMID: 33116498 DOI: 10.2147/IJN.S257312] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
72 Kijima T, Nakagawa H, Shimonosono M, Chandramouleeswaran PM, Hara T, Sahu V, Kasagi Y, Kikuchi O, Tanaka K, Giroux V, Muir AB, Whelan KA, Ohashi S, Naganuma S, Klein-Szanto AJ, Shinden Y, Sasaki K, Omoto I, Kita Y, Muto M, Bass AJ, Diehl JA, Ginsberg GG, Doki Y, Mori M, Uchikado Y, Arigami T, Avadhani NG, Basu D, Rustgi AK, Natsugoe S. Three-Dimensional Organoids Reveal Therapy Resistance of Esophageal and Oropharyngeal Squamous Cell Carcinoma Cells. Cell Mol Gastroenterol Hepatol 2019;7:73-91. [PMID: 30510992 DOI: 10.1016/j.jcmgh.2018.09.003] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 9.8] [Reference Citation Analysis]
73 Xu J, Pan X, Hu Z. MiR-502 mediates esophageal cancer cell TE1 proliferation by promoting AKT phosphorylation. Biochem Biophys Res Commun 2018;501:119-23. [PMID: 29709473 DOI: 10.1016/j.bbrc.2018.04.188] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
74 Rastgar-Moghadam A, Mehramiz M, Shahidsales S, Entezari M, Hassanian SM, Talebian S, Nourbakhsh M, Ferns GA, Avan A. Association of a genetic variant in ATP-binding cassette sub-family B member 1 gene with poor prognosis in patients with squamous cell carcinoma of the esophagus. IUBMB Life 2019;71:1252-8. [PMID: 30865384 DOI: 10.1002/iub.2034] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
75 Ye J, Ma J, Liu C, Huang J, Wang L, Zhong X. A novel iron(II) phenanthroline complex exhibits anticancer activity against TFR1-overexpressing esophageal squamous cell carcinoma cells through ROS accumulation and DNA damage. Biochem Pharmacol 2019;166:93-107. [PMID: 31078603 DOI: 10.1016/j.bcp.2019.05.013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
76 Liu T, Li P, Li J, Qi Q, Sun Z, Shi S, Xie Y, Liu S, Wang Y, Du L, Wang C. Exosomal and intracellular miR-320b promotes lymphatic metastasis in esophageal squamous cell carcinoma. Mol Ther Oncolytics 2021;23:163-80. [PMID: 34729394 DOI: 10.1016/j.omto.2021.09.003] [Reference Citation Analysis]
77 Wang Y, Wu N, Luo X, Zhang X, Liao Q, Wang J. SOX2OT, a novel tumor-related long non-coding RNA. Biomed Pharmacother 2020;123:109725. [PMID: 31865145 DOI: 10.1016/j.biopha.2019.109725] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
78 Sun L, Cao J, Guo C, Burnett J, Yang Z, Ran Y, Sun D. Associations of carboxypeptidase 4 with ALDH1A1 expression and their prognostic value in esophageal squamous cell carcinoma. Dis Esophagus 2017;30:1-5. [PMID: 28475748 DOI: 10.1093/dote/dox011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
79 Chen X, Zhang Y, Shi Y, Niu T, Li B, Guo L, Qiao Y, Zhao J, Yuan B, Liu K. Evolution of DNA aptamers against esophageal squamous cell carcinoma using cell-SELEX. Analyst 2021;146:4180-7. [PMID: 34105524 DOI: 10.1039/d1an00634g] [Reference Citation Analysis]
80 Deng HY, Wang YC, Ni PZ, Lin YD, Chen LQ. Long noncoding RNAs are novel potential prognostic biomarkers for esophageal squamous cell carcinoma: an overview. J Thorac Dis. 2016;8:E653-E659. [PMID: 27621894 DOI: 10.21037/jtd.2016.07.01] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
81 Li M, Wan X, Wang Y, Sun Y, Yang G, Wang L. Time trends of esophageal and gastric cancer mortality in China, 1991-2009: an age-period-cohort analysis. Sci Rep 2017;7:6797. [PMID: 28754910 DOI: 10.1038/s41598-017-07071-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
82 Zhu ZJ, Pang Y, Jin G, Zhang HY, Wang WH, Liu JW, Tuo GX, Wu P, Yang Y, Wang ZQ, Wang K. Hypoxia induces chemoresistance of esophageal cancer cells to cisplatin through regulating the lncRNA-EMS/miR-758-3p/WTAP axis. Aging (Albany NY) 2021;13:17155-76. [PMID: 34081626 DOI: 10.18632/aging.203062] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
83 Shao Y, Hua Z, Zhao L, Shen Y, Guo X, Niu C, Wei W, Liu F. Time Trends of Gastrointestinal Cancers Incidence and Mortality in Yangzhong From 1991 to 2015: An Updated Age-Period-Cohort Analysis. Front Oncol 2018;8:638. [PMID: 30619771 DOI: 10.3389/fonc.2018.00638] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
84 Senthebane DA, Jonker T, Rowe A, Thomford NE, Munro D, Dandara C, Wonkam A, Govender D, Calder B, Soares NC, Blackburn JM, Parker MI, Dzobo K. The Role of Tumor Microenvironment in Chemoresistance: 3D Extracellular Matrices as Accomplices. Int J Mol Sci 2018;19:E2861. [PMID: 30241395 DOI: 10.3390/ijms19102861] [Cited by in Crossref: 51] [Cited by in F6Publishing: 49] [Article Influence: 12.8] [Reference Citation Analysis]
85 Enesca A. Enhancing the Photocatalytic Activity of SnO2-TiO2 and ZnO-TiO2 Tandem Structures Toward Indoor Air Decontamination. Front Chem 2020;8:583270. [PMID: 33324610 DOI: 10.3389/fchem.2020.583270] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
86 Aoyama I, Ohashi S, Amanuma Y, Hirohashi K, Mizumoto A, Funakoshi M, Tsurumaki M, Nakai Y, Tanaka K, Hanada M, Uesaka A, Chiba T, Muto M. Establishment of a Quick and Highly Accurate Breath Test for ALDH2 Genotyping. Clin Transl Gastroenterol 2017;8:e96. [PMID: 28594397 DOI: 10.1038/ctg.2017.24] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
87 Feng YF, Lei YY, Lu JB, Xi SY, Zhang Y, Huang QT, Wu QL, Wang F. RIT1 suppresses esophageal squamous cell carcinoma growth and metastasis and predicts good prognosis. Cell Death Dis 2018;9:1085. [PMID: 30348939 DOI: 10.1038/s41419-018-0979-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
88 Mangalaparthi KK, Patel K, Khan AA, Manoharan M, Karunakaran C, Murugan S, Gupta R, Gupta R, Khanna-Gupta A, Chaudhuri A, Kumar P, Nair B, Kumar RV, Prasad TSK, Chatterjee A, Pandey A, Gowda H. Mutational Landscape of Esophageal Squamous Cell Carcinoma in an Indian Cohort. Front Oncol 2020;10:1457. [PMID: 32974170 DOI: 10.3389/fonc.2020.01457] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
89 Omura G, Ando M, Ebihara Y, Saito Y, Kobayashi K, Fukuoka O, Akashi K, Yoshida M, Asakage T, Yamasoba T. The prognostic value of TP53 mutations in hypopharyngeal squamous cell carcinoma. BMC Cancer 2017;17:898. [PMID: 29282038 DOI: 10.1186/s12885-017-3913-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
90 Jin Z, Chen D, Chen M, Wang C, Zhang B, Zhang J, Zhu C, Shen J. (Neo)adjuvant Chemoradiotherapy is Beneficial to the Long-term Survival of Locally Advanced Esophageal Squamous Cell Carcinoma: A Network Meta-analysis. World J Surg 2021. [PMID: 34482411 DOI: 10.1007/s00268-021-06301-2] [Reference Citation Analysis]
91 Yu X, van Munster SN, Zhang Y, Xue L, Fleischer DE, Weusten BLAM, Lu N, Dawsey SSM, Bergman JJGHM, Wang G. Durability of radiofrequency ablation for treatment of esophageal squamous cell neoplasia: 5-year follow-up of a treated cohort in China. Gastrointest Endosc 2019;89:736-748.e2. [PMID: 30905354 DOI: 10.1016/j.gie.2018.10.030] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
92 Liu T, Wang Z, Zhou R, Liang W. Focally amplified lncRNA on chromosome 1 regulates apoptosis of esophageal cancer cells via DRP1 and mitochondrial dynamics. IUBMB Life 2019;71:254-60. [PMID: 30501006 DOI: 10.1002/iub.1971] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
93 Wu H, Minamide T, Yano T. Role of photodynamic therapy in the treatment of esophageal cancer. Dig Endosc 2019;31:508-16. [PMID: 30667112 DOI: 10.1111/den.13353] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 9.7] [Reference Citation Analysis]
94 Liu X, Zhao Y, Zhang W, Gao Y, Huo M, Liu M, Xiao Z, Liang S, Xu N, Zhu H. Inhibition of survivin enhances radiosensitivity of esophageal cancer cells by switching radiation-induced senescence to apoptosis. Onco Targets Ther 2018;11:3087-100. [PMID: 29872320 DOI: 10.2147/OTT.S166798] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
95 Liang Y, Li S, Zheng G, Zhang L. β-elemene suppresses the malignant behavior of esophageal cancer cells by regulating the phosphorylation of AKT. Acta Histochemica 2020;122:151538. [DOI: 10.1016/j.acthis.2020.151538] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
96 Wu X, Han R, Zhong Y, Weng N, Zhang A. Post treatment NLR is a predictor of response to immune checkpoint inhibitor therapy in patients with esophageal squamous cell carcinoma. Cancer Cell Int 2021;21:356. [PMID: 34233686 DOI: 10.1186/s12935-021-02072-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
97 Chen L, You C, Jin X, Zhou L, Huang L, Wang Y. Cytoskeleton-associated protein 4 is a novel serodiagnostic marker for esophageal squamous-cell carcinoma. Onco Targets Ther 2018;11:8221-6. [PMID: 30538491 DOI: 10.2147/OTT.S183790] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
98 Ma S, Lu CC, Yang LY, Wang JJ, Wang BS, Cai HQ, Hao JJ, Xu X, Cai Y, Zhang Y, Wang MR. ANXA2 promotes esophageal cancer progression by activating MYC-HIF1A-VEGF axis. J Exp Clin Cancer Res. 2018;37:183. [PMID: 30081903 DOI: 10.1186/s13046-018-0851-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
99 Wang Y, Xie Z, Lu H. Significance of halofuginone in esophageal squamous carcinoma cell apoptosis through HIF-1α-FOXO3a pathway. Life Sci 2020;257:118104. [PMID: 32679143 DOI: 10.1016/j.lfs.2020.118104] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
100 Xiong Z, Ren S, Chen H, Liu Y, Huang C, Zhang YL, Odera JO, Chen T, Kist R, Peters H, Garman K, Sun Z, Chen X. PAX9 regulates squamous cell differentiation and carcinogenesis in the oro-oesophageal epithelium. J Pathol 2018;244:164-75. [PMID: 29055049 DOI: 10.1002/path.4998] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
101 Liu T, Yang K, Yu J, Cao Y, Ren J, Hao J, Pan B, Ma S, Yang L, Cai Y, Wang M, Zhang Y. Co-targeting PLK1 and mTOR induces synergistic inhibitory effects against esophageal squamous cell carcinoma. J Mol Med 2018;96:807-17. [DOI: 10.1007/s00109-018-1663-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
102 Uemura N, Kondo T. Current status of proteomics of esophageal carcinoma. Expert Rev Proteomics 2016;13:1029-40. [PMID: 27678273 DOI: 10.1080/14789450.2016.1242418] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
103 Jesinghaus M, Brühl F, Steiger K, Klare P, Reiser M, Scheiter A, Konukiewitz B, Kuhn P, Münch S, Quante M, Schmid RM, Wilhelm D, Feith M, Friess H, Combs SE, Saur D, Boxberg M, Weichert W. Cellular Dissociation Grading Based on the Parameters Tumor Budding and Cell Nest Size in Pretherapeutic Biopsy Specimens Allows for Prognostic Patient Stratification in Esophageal Squamous Cell Carcinoma Independent From Clinical Staging. Am J Surg Pathol 2019;43:618-27. [PMID: 30807302 DOI: 10.1097/PAS.0000000000001230] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
104 Ohashi W, Hara T, Takagishi T, Hase K, Fukada T. Maintenance of Intestinal Epithelial Homeostasis by Zinc Transporters. Dig Dis Sci. 2019;64:2404-2415. [PMID: 30830525 DOI: 10.1007/s10620-019-05561-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
105 Guan X, Yao Y, Bao G, Wang Y, Zhang A, Zhong X. Diagnostic model of combined ceRNA and DNA methylation related genes in esophageal carcinoma. PeerJ 2020;8:e8831. [PMID: 32266120 DOI: 10.7717/peerj.8831] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
106 Wen Q, Yang Z, Zhu J, Qiu Q, Dai H, Feng A, Xing L. Pretreatment CT-Based Radiomics Signature as a Potential Imaging Biomarker for Predicting the Expression of PD-L1 and CD8+TILs in ESCC. Onco Targets Ther. 2020;13:12003-12013. [PMID: 33244242 DOI: 10.2147/ott.s261068] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
107 Pang J, Pan H, Yang C, Meng P, Xie W, Li J, Li Y, Xiao SY. Prognostic Value of Immune-Related Multi-IncRNA Signatures Associated With Tumor Microenvironment in Esophageal Cancer. Front Genet 2021;12:722601. [PMID: 34659345 DOI: 10.3389/fgene.2021.722601] [Reference Citation Analysis]
108 You BH, Yoon JH, Kang H, Lee EK, Lee SK, Nam JW. HERES, a lncRNA that regulates canonical and noncanonical Wnt signaling pathways via interaction with EZH2. Proc Natl Acad Sci U S A 2019;116:24620-9. [PMID: 31732666 DOI: 10.1073/pnas.1912126116] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
109 Morshedi K, Borran S, Ebrahimi MS, Masoud Khooy MJ, Seyedi ZS, Amiri A, Abbasi-Kolli M, Fallah M, Khan H, Sahebkar A, Mirzaei H. Therapeutic effect of curcumin in gastrointestinal cancers: A comprehensive review. Phytother Res 2021. [PMID: 34173992 DOI: 10.1002/ptr.7119] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
110 Li L, Liu M, Lin JB, Hong XB, Chen WX, Guo H, Xu LY, Xu YW, Li EM, Peng YH. Diagnostic Value of Autoantibodies against Ezrin in Esophageal Squamous Cell Carcinoma. Dis Markers. 2017;2017:2534648. [PMID: 28298808 DOI: 10.1155/2017/2534648] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
111 Zhuang X, Chen Z, Wang J, Chen J, Wu X, Wang Y, Chen C, Deng G, Qian K, Bai Y. Clinicopathological features and outcomes of esophageal lesions containing a basal layer type squamous cell carcinoma component. Cancer Manag Res 2019;11:8507-16. [PMID: 31572005 DOI: 10.2147/CMAR.S212380] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
112 Wang W, Wei C, Li P, Wang L, Li W, Chen K, Zhang J, Zhang W, Jiang G. Integrative analysis of mRNA and lncRNA profiles identified pathogenetic lncRNAs in esophageal squamous cell carcinoma. Gene 2018;661:169-75. [PMID: 29604464 DOI: 10.1016/j.gene.2018.03.066] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 4.5] [Reference Citation Analysis]
113 Yamamoto K, Takano K, Kondo A, Kurose M, Obata K, Himi T. Clinical and Prognostic Analysis of Hypopharyngeal Squamous Cell Carcinoma with Synchronous and Metachronous Multiple Malignancies. In Vivo 2018;32:165-70. [PMID: 29275315 DOI: 10.21873/invivo.11220] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
114 Liu H, Zhang Q, Lou Q, Zhang X, Cui Y, Wang P, Yang F, Wu F, Wang J, Fan T, Li S. Differential Analysis of lncRNA, miRNA and mRNA Expression Profiles and the Prognostic Value of lncRNA in Esophageal Cancer. Pathol Oncol Res 2020;26:1029-39. [PMID: 30972633 DOI: 10.1007/s12253-019-00655-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
115 Shu J, Ma J, Ren X, Wang J, Wang Y, Zhang K, Yu H, Guo X, Li Z. The Abnormal Glycopatterns of Salivary Glycoproteins in Esophageal Squamous Cell Carcinoma Patients. Front Chem 2021;9:637730. [PMID: 33748076 DOI: 10.3389/fchem.2021.637730] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
116 Hazawa M, Lin DC, Handral H, Xu L, Chen Y, Jiang YY, Mayakonda A, Ding LW, Meng X, Sharma A, Samuel S, Movahednia MM, Wong RW, Yang H, Tong C, Koeffler HP. ZNF750 is a lineage-specific tumour suppressor in squamous cell carcinoma. Oncogene 2017;36:2243-54. [PMID: 27819679 DOI: 10.1038/onc.2016.377] [Cited by in Crossref: 54] [Cited by in F6Publishing: 51] [Article Influence: 9.0] [Reference Citation Analysis]
117 Wu Y, Chen X, Liang Y, Li J, Zhang K, Dai L, Guan X, Wang K, Bai Y. Overexpression of long non-coding RNA SOX2OT promotes esophageal squamous cell carcinoma growth. Cancer Cell Int 2018;18:76. [PMID: 29849506 DOI: 10.1186/s12935-018-0570-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
118 Oshikiri T, Yasuda T, Hasegawa H, Yamamoto M, Kanaji S, Yamashita K, Matsuda T, Sumi Y, Nakamura T, Fujino Y, Tominaga M, Suzuki S, Kakeji Y. Short-term outcomes and one surgeon’s learning curve for thoracoscopic esophagectomy performed with the patient in the prone position. Surg Today 2017;47:313-9. [DOI: 10.1007/s00595-016-1378-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
119 Yokoi A, Ekuni D, Hata H, Yamane-Takeuchi M, Maruyama T, Yamanaka R, Morita M. Relationship between acetaldehyde concentration in mouth air and characteristics of microbiota of tongue dorsum in Japanese healthy adults: a cross-sectional study. J Appl Oral Sci 2019;27:e20180635. [PMID: 31215600 DOI: 10.1590/1678-7757-2018-0635] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
120 Chen X, Hu H, Liu J, Yang Y, Liu G, Ying X, Chen Y, Li B, Ye C, Wu D, Duan S. FOXF2 promoter methylation is associated with prognosis in esophageal squamous cell carcinoma. Tumour Biol 2017;39:1010428317692230. [PMID: 28222662 DOI: 10.1177/1010428317692230] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
121 Fankhauser CD, Mostafid H. Genetic polymorphisms may explain association between alcohol consumption and bladder cancer risk in East Asian men. Transl Androl Urol 2018;7:S252-4. [PMID: 29928627 DOI: 10.21037/tau.2018.04.17] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
122 Wang L, Han H, Wang Z, Shi L, Yang M, Qin Y. Targeting the Microenvironment in Esophageal Cancer. Front Cell Dev Biol 2021;9:684966. [PMID: 34513829 DOI: 10.3389/fcell.2021.684966] [Reference Citation Analysis]
123 Sharma U, Barwal TS, Acharya V, Singh K, Rana MK, Singh SK, Prakash H, Bishayee A, Jain A. Long Non-Coding RNAs as Strategic Molecules to Augment the Radiation Therapy in Esophageal Squamous Cell Carcinoma. Int J Mol Sci 2020;21:E6787. [PMID: 32947897 DOI: 10.3390/ijms21186787] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
124 . UEG Week 2016 Poster Presentations. United European Gastroenterology Journal 2016;4:A157-720. [DOI: 10.1177/2050640616663689] [Cited by in Crossref: 14] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
125 Tarazi M, Chidambaram S, Markar SR. Risk Factors of Esophageal Squamous Cell Carcinoma beyond Alcohol and Smoking. Cancers (Basel) 2021;13:1009. [PMID: 33671026 DOI: 10.3390/cancers13051009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
126 Roy R, Kandimalla R, Sonohara F, Koike M, Kodera Y, Takahashi N, Yamada Y, Goel A. A comprehensive methylation signature identifies lymph node metastasis in esophageal squamous cell carcinoma. Int J Cancer 2019;144:1160-9. [PMID: 30006931 DOI: 10.1002/ijc.31755] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
127 Zhou M, Mao Y, Yu S, Li Y, Yin R, Zhang Q, Lu T, Sun R, Lin S, Qian Y, Xu Y, Fan H. LINC00673 Represses CDKN2C and Promotes the Proliferation of Esophageal Squamous Cell Carcinoma Cells by EZH2-Mediated H3K27 Trimethylation. Front Oncol 2020;10:1546. [PMID: 33014799 DOI: 10.3389/fonc.2020.01546] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
128 Amanuma Y, Horimatsu T, Ohashi S, Tamaoki M, Muto M. Association of local complete response with prognosis after salvage photodynamic therapy for esophageal squamous cell carcinoma. Digestive Endoscopy 2021;33:355-63. [DOI: 10.1111/den.13730] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
129 Marabotto E, Pellegatta G, Sheijani AD, Ziola S, Zentilin P, De Marzo MG, Giannini EG, Ghisa M, Barberio B, Scarpa M, Angriman I, Fassan M, Savarino V, Savarino E. Prevention Strategies for Esophageal Cancer-An Expert Review. Cancers (Basel) 2021;13:2183. [PMID: 34062788 DOI: 10.3390/cancers13092183] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
130 Hisano O, Nonoshita T, Hirata H, Sasaki T, Watanabe H, Wakiyama H, Ono M, Ohga S, Honda H. Additional radiotherapy following endoscopic submucosal dissection for T1a-MM/T1b-SM esophageal squamous cell carcinoma improves locoregional control. Radiat Oncol 2018;13:14. [PMID: 29378603 DOI: 10.1186/s13014-018-0960-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
131 Pu J, Zhang T, Zhang D, He K, Chen Y, Sun X, Long W. High-Expression of Cytoplasmic Poly (A) Binding Protein 1 (PABPC1) as a Prognostic Biomarker for Early-Stage Esophageal Squamous Cell Carcinoma. Cancer Manag Res 2021;13:5361-72. [PMID: 34262344 DOI: 10.2147/CMAR.S317631] [Reference Citation Analysis]
132 Zhou X, Wen W, Zhu J, Huang Z, Zhang L, Zhang H, Qi LW, Shan X, Wang T, Cheng W, Zhu D, Yin Y, Chen Y, Zhu W, Shu Y, Liu P. A six-microRNA signature in plasma was identified as a potential biomarker in diagnosis of esophageal squamous cell carcinoma. Oncotarget. 2017;8:34468-34480. [PMID: 28380431 DOI: 10.18632/oncotarget.16519] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 8.0] [Reference Citation Analysis]
133 Lin JX, Li P, Huang CM. Comment on "Clinical and Prognostic Features of Patients With Esophageal Cancer and Multiple Primary Cancers". Ann Surg 2019;269:e75. [PMID: 31082925 DOI: 10.1097/SLA.0000000000002833] [Reference Citation Analysis]
134 Liang M, Pan Z, Yu F, Chen C. Long noncoding RNA SNHG12 suppresses esophageal squamous cell carcinoma progression through competing endogenous RNA networks. Clin Transl Oncol 2020;22:1786-95. [PMID: 32086782 DOI: 10.1007/s12094-020-02317-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
135 Wang X, Liu H, Zhang Q, Zhang X, Qin Y, Zhu G, Dang J, Wang F, Yang X, Fan R. LINC00514 promotes lipogenesis and tumor progression in esophageal squamous cell carcinoma by sponging miR‑378a‑5p to enhance SPHK1 expression. Int J Oncol 2021;59:86. [PMID: 34533201 DOI: 10.3892/ijo.2021.5266] [Reference Citation Analysis]
136 Cao Y, Gao A, Li X, Min H, He C, Sun X, Ding WQ, Zhou J. Elevated TAB182 enhances the radioresistance of esophageal squamous cell carcinoma through G2-M checkpoint modulation. Cancer Med 2021;10:3101-12. [PMID: 33787085 DOI: 10.1002/cam4.3879] [Reference Citation Analysis]
137 Zeng H, Yang H, Song Y, Fang D, Chen L, Zhao Z, Wang C, Xie S. Transcriptional inhibition by CDK7/9 inhibitor SNS-032 suppresses tumor growth and metastasis in esophageal squamous cell carcinoma. Cell Death Dis 2021;12:1048. [PMID: 34741018 DOI: 10.1038/s41419-021-04344-w] [Reference Citation Analysis]
138 Sonohara F, Gao F, Iwata N, Kanda M, Koike M, Takahashi N, Yamada Y, Kodera Y, Wang X, Goel A. Genome-wide Discovery of a Novel Gene-expression Signature for the Identification of Lymph Node Metastasis in Esophageal Squamous Cell Carcinoma. Ann Surg 2019;269:879-86. [PMID: 29240008 DOI: 10.1097/SLA.0000000000002622] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
139 Etemadi A, Dawsey SM, Abnet CC, Mwachiro MM. Predicting the risk of esophageal high-grade lesions in opportunistic screening. Gastrointest Endosc 2020;92:1136-7. [PMID: 33160493 DOI: 10.1016/j.gie.2020.05.051] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
140 Domoto T, Uehara M, Bolidong D, Minamoto T. Glycogen Synthase Kinase 3β in Cancer Biology and Treatment. Cells 2020;9:E1388. [PMID: 32503133 DOI: 10.3390/cells9061388] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
141 Li HM, Yu YK, Liu Q, Wei XF, Zhang J, Zhang RX, Sun HB, Wang ZF, Xing WQ, Li Y. LncRNA SNHG1 Regulates the Progression of Esophageal Squamous Cell Cancer by the miR-204/HOXC8 Axis. Onco Targets Ther 2020;13:757-67. [PMID: 32158227 DOI: 10.2147/OTT.S224550] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
142 Egebjerg K, Garbyal RS, Hasselby JP, Baeksgaard L, Mau-Sørensen M. Prevalence of HER2 overexpression and amplification in squamous cell carcinoma of the esophagus: A systematic review and meta-analysis. Crit Rev Oncol Hematol 2021;161:103339. [PMID: 33865993 DOI: 10.1016/j.critrevonc.2021.103339] [Reference Citation Analysis]
143 Liu H, Zhao J, Fu R, Zhu C, Fan D. The ginsenoside Rk3 exerts anti-esophageal cancer activity in vitro and in vivo by mediating apoptosis and autophagy through regulation of the PI3K/Akt/mTOR pathway. PLoS One 2019;14:e0216759. [PMID: 31091245 DOI: 10.1371/journal.pone.0216759] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 6.7] [Reference Citation Analysis]
144 Jiang Y, Xu D, Song H, Qiu B, Tian D, Li Z, Ji Y, Wang J. Inflammation and nutrition-based biomarkers in the prognosis of oesophageal cancer: a systematic review and meta-analysis. BMJ Open 2021;11:e048324. [PMID: 34593492 DOI: 10.1136/bmjopen-2020-048324] [Reference Citation Analysis]
145 Jesinghaus M, Steiger K, Slotta-Huspenina J, Drecoll E, Pfarr N, Meyer P, Konukiewitz B, Bettstetter M, Wieczorek K, Ott K, Feith M, Langer R, Weichert W, Specht K, Boxberg M. Increased intraepithelial CD3+ T-lymphocytes and high PD-L1 expression on tumor cells are associated with a favorable prognosis in esophageal squamous cell carcinoma and allow prognostic immunogenic subgrouping. Oncotarget 2017;8:46756-68. [PMID: 28657901 DOI: 10.18632/oncotarget.18606] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 7.5] [Reference Citation Analysis]
146 Pan P, Peiffer DS, Huang YW, Oshima K, Stoner GD, Wang LS. Inhibition of the development of N-nitrosomethylbenzylamine-induced esophageal tumors in rats by strawberries and aspirin, alone and in combination. J Berry Res 2018;8:137-46. [PMID: 29977412 DOI: 10.3233/JBR-170291] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
147 Guan C, Liu Z, Lu C, Xiao M, Shi H, Ni R, Bian Z. Nucleolar spindle-associated protein 1 promotes tumorigenesis and predicts poor prognosis in human esophageal squamous cell carcinoma. J Cell Biochem 2019. [PMID: 30793360 DOI: 10.1002/jcb.28452] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
148 Jesinghaus M, Boxberg M, Wilhelm D, Münch S, Dapper H, Quante M, Schlag C, Lange S, Budczies J, Konukiewitz B, Mollenhauer M, Schlitter AM, Becker KF, Feith M, Friess H, Steiger K, Combs SE, Weichert W. Post-neoadjuvant cellular dissociation grading based on tumour budding and cell nest size is associated with therapy response and survival in oesophageal squamous cell carcinoma. Br J Cancer 2019;121:1050-7. [PMID: 31690830 DOI: 10.1038/s41416-019-0623-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
149 Zhao R, Cao X, Jin S, Li R, Zhong Q, Jiang M, Han J, Guo C, Zong H. LncRNA BC200 Promotes Esophageal Squamous Cell Cancer Migration and Invasion and Can Regulate ATF4 Expression. Front Oncol 2020;10:1392. [PMID: 32974142 DOI: 10.3389/fonc.2020.01392] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
150 Kurihara T, Itoh S, Kimura Y, Oki E, Yoshizumi T, Matuo M, Yasumatsu R, Sugimachi K, Morita M, Kusumoto T, Fukuzawa K, Yoshida N, Baba H, Mori M. Feasibility of hepatic resection for liver metastasis of head-and-neck carcinoma or esophageal carcinoma: a multi-center experience. Surg Today 2021. [PMID: 34032927 DOI: 10.1007/s00595-021-02305-6] [Reference Citation Analysis]
151 Wang Q, Lv Q, Bian H, Yang L, Guo KL, Ye SS, Dong XF, Tao LL. A novel tumor suppressor SPINK5 targets Wnt/β-catenin signaling pathway in esophageal cancer. Cancer Med 2019;8:2360-71. [PMID: 30868765 DOI: 10.1002/cam4.2078] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
152 Gu MM, Li M, Gao D, Liu LH, Lang Y, Yang SM, Ou H, Huang B, Zhou PK, Shang ZF. The vanillin derivative 6-bromine-5-hydroxy-4-methoxybenzaldehyde induces aberrant mitotic progression and enhances radio-sensitivity accompanying suppression the expression of PLK1 in esophageal squamous cell carcinoma. Toxicol Appl Pharmacol 2018;348:76-84. [PMID: 29679654 DOI: 10.1016/j.taap.2018.04.021] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
153 Yao W, Chen Q, Li S, Jia X, Xu L, Wei L. RELT promotes the growth of esophageal squamous cell carcinoma by activating the NF-κB pathway. Cell Cycle 2021;20:1231-41. [PMID: 34121605 DOI: 10.1080/15384101.2021.1924451] [Reference Citation Analysis]
154 Zang HL, Ji FJ, Ju HY, Tian XF. Circular RNA AKT3 governs malignant behaviors of esophageal cancer cells by sponging miR-17-5p. World J Gastroenterol 2021; 27(3): 240-254 [PMID: 33519139 DOI: 10.3748/wjg.v27.i3.240] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
155 Doucet-O'Hare TT, Sharma R, Rodić N, Anders RA, Burns KH, Kazazian HH Jr. Somatically Acquired LINE-1 Insertions in Normal Esophagus Undergo Clonal Expansion in Esophageal Squamous Cell Carcinoma. Hum Mutat 2016;37:942-54. [PMID: 27319353 DOI: 10.1002/humu.23027] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 5.7] [Reference Citation Analysis]
156 Zheng H, Tang H, Wang H, Fang Y, Shen Y, Feng M, Xu S, Fan H, Ge D, Wang Q, Tan L. Nomogram to predict lymph node metastasis in patients with early oesophageal squamous cell carcinoma. British Journal of Surgery 2018;105:1464-70. [DOI: 10.1002/bjs.10882] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
157 Abnet CC, Arnold M, Wei WQ. Epidemiology of Esophageal Squamous Cell Carcinoma. Gastroenterology. 2018;154:360-373. [PMID: 28823862 DOI: 10.1053/j.gastro.2017.08.023] [Cited by in Crossref: 355] [Cited by in F6Publishing: 371] [Article Influence: 71.0] [Reference Citation Analysis]
158 Bie J, Hu X, Yang M, Shi X, Zhang X, Wang Z. PTK7 promotes the malignant properties of cancer stem-like cells in esophageal squamous cell lines. Hum Cell 2020;33:356-65. [PMID: 31894477 DOI: 10.1007/s13577-019-00309-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
159 Li X, Chen D, Li M, Gao X, Shi G, Zhao H. The CADM2/Akt pathway is involved in the inhibitory effect of miR-21-5p downregulation on proliferation and apoptosis in esophageal squamous cell carcinoma cells. Chem Biol Interact. 2018;288:76-82. [PMID: 29680210 DOI: 10.1016/j.cbi.2018.04.021] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
160 Natsuizaka M, Whelan KA, Kagawa S, Tanaka K, Giroux V, Chandramouleeswaran PM, Long A, Sahu V, Darling DS, Que J, Yang Y, Katz JP, Wileyto EP, Basu D, Kita Y, Natsugoe S, Naganuma S, Klein-Szanto AJ, Diehl JA, Bass AJ, Wong KK, Rustgi AK, Nakagawa H. Interplay between Notch1 and Notch3 promotes EMT and tumor initiation in squamous cell carcinoma. Nat Commun 2017;8:1758. [PMID: 29170450 DOI: 10.1038/s41467-017-01500-9] [Cited by in Crossref: 68] [Cited by in F6Publishing: 77] [Article Influence: 13.6] [Reference Citation Analysis]
161 Hirohata R, Hamai Y, Emi M, Kurokawa T, Yoshikawa T, Ohsawa M, Tadokoro K, Okada M. Prediction of the tumor response and survival based on computed tomography in esophageal squamous cell carcinoma after trimodality therapy. Surg Today 2021;51:1496-505. [PMID: 33797639 DOI: 10.1007/s00595-021-02277-7] [Reference Citation Analysis]
162 Bao Y, Wang Q, Guo Y, Chen Z, Li K, Yang Y, Zhang H, Dong H, Shen K, Yang W. PRSS8 methylation and its significance in esophageal squamous cell carcinoma. Oncotarget 2016;7:28540-55. [PMID: 27081034 DOI: 10.18632/oncotarget.8677] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
163 Yuan J, Jiang Q, Gong T, Fan D, Zhang J, Chen F, Zhu X, Wang X, Qiao Y, Chen H, Liu Z, Su J. Loss of grand histone H3 lysine 27 trimethylation domains mediated transcriptional activation in esophageal squamous cell carcinoma. NPJ Genom Med 2021;6:65. [PMID: 34381055 DOI: 10.1038/s41525-021-00232-6] [Reference Citation Analysis]
164 Masaoka H, Matsuo K, Sawada N, Yamaji T, Goto A, Shimazu T, Iwasaki M, Inoue M, Eto M, Tsugane S; for the Japan Public Health Center-based Prospective Study Group. Alcohol consumption and bladder cancer risk with or without the flushing response: The Japan Public Health Center-based Prospective Study: Alcohol consumption and bladder cancer. Int J Cancer 2017;141:2480-8. [DOI: 10.1002/ijc.31028] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
165 Li R, Pang XF, Huang ZG, Yang LH, Peng ZG, Ma J, He RQ. Overexpression of UBE2C in esophageal squamous cell carcinoma tissues and molecular analysis. BMC Cancer 2021;21:996. [PMID: 34488675 DOI: 10.1186/s12885-021-08634-6] [Reference Citation Analysis]
166 Bolidong D, Domoto T, Uehara M, Sabit H, Okumura T, Endo Y, Nakada M, Ninomiya I, Miyashita T, Wong RW, Minamoto T. Potential therapeutic effect of targeting glycogen synthase kinase 3β in esophageal squamous cell carcinoma. Sci Rep 2020;10:11807. [PMID: 32678196 DOI: 10.1038/s41598-020-68713-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
167 Yang F, Wen S, Zhang Y, Xu Y, Lv H, Zhu Y, Wang M, Su P, Huang C, Tian Z. Identifying potential metastasis-related long non-coding RNAs, microRNAs, and message RNAs in the esophageal squamous cell carcinoma. J Cell Biochem. 2019;120:13202-13215. [PMID: 30891809 DOI: 10.1002/jcb.28594] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
168 Su M, Xiao Y, Ma J, Cao D, Zhou Y, Wang H, Liao Q, Wang W. Long non-coding RNAs in esophageal cancer: molecular mechanisms, functions, and potential applications. J Hematol Oncol 2018;11:118. [PMID: 30223861 DOI: 10.1186/s13045-018-0663-8] [Cited by in Crossref: 24] [Cited by in F6Publishing: 30] [Article Influence: 6.0] [Reference Citation Analysis]
169 Wu X, Zhang H, Sui Z, Wang Y, Yu Z. The biological role of the CXCL12/CXCR4 axis in esophageal squamous cell carcinoma. Cancer Biol Med 2021:j. [PMID: 33710803 DOI: 10.20892/j.issn.2095-3941.2020.0140] [Reference Citation Analysis]
170 Lu YX, Chen DL, Wang DS, Chen LZ, Mo HY, Sheng H, Bai L, Wu QN, Yu HE, Xie D, Yun JP, Zeng ZL, Wang F, Ju HQ, Xu RH. Melatonin enhances sensitivity to fluorouracil in oesophageal squamous cell carcinoma through inhibition of Erk and Akt pathway. Cell Death Dis 2016;7:e2432. [PMID: 27787516 DOI: 10.1038/cddis.2016.330] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 4.8] [Reference Citation Analysis]
171 Wang X, Zhang B, Chen X, Mo H, Wu D, Lan B, Li Q, Xu B, Huang J. Lactate dehydrogenase and baseline markers associated with clinical outcomes of advanced esophageal squamous cell carcinoma patients treated with camrelizumab (SHR-1210), a novel anti-PD-1 antibody. Thorac Cancer 2019;10:1395-401. [PMID: 31017739 DOI: 10.1111/1759-7714.13083] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
172 Sugimoto K, Ito T, Woo J, Tully E, Sato K, Orita H, Brock MV, Gabrielson E. Prognostic Impact of Phosphorylated Discoidin Domain Receptor-1 in Esophageal Cancer. J Surg Res 2019;235:479-86. [PMID: 30691832 DOI: 10.1016/j.jss.2018.10.032] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
173 Ma Q. MiR-219-5p suppresses cell proliferation and cell cycle progression in esophageal squamous cell carcinoma by targeting CCNA2. Cell Mol Biol Lett 2019;24:4. [PMID: 30766610 DOI: 10.1186/s11658-018-0129-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
174 Yang LY, Cheng ZJ, Liu Z, Wang D, Zhang N, Fan ZL, Cai HQ, Zhang Y, Cai Y, Xu X, Wang JH, Du GH, Hao JJ, Wang MR. Remarkable inhibition effects of afatinib alone or combining with paclitaxel in esophageal squamous cell carcinoma. J Gastroenterol Hepatol 2021. [PMID: 33721913 DOI: 10.1111/jgh.15490] [Reference Citation Analysis]
175 Lu Y, Guan L, Xu M, Wang F. The efficacy and safety of antibodies targeting PD-1 for treatment in advanced esophageal cancer: A systematic review and meta-analysis. Transl Oncol 2021;14:101083. [PMID: 33784583 DOI: 10.1016/j.tranon.2021.101083] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
176 Zhao S, Jiang Y, Tian T, Zhao J, Xie Y, Chen X, Lu J, Yang F, Li H, Liu K, Dong Z. Jie Du Tong Ye San Prevents N-Nitrosomethylbenzylamine-Induced Esophageal Carcinogenesis via Inhibition of Inflammation and Proliferation. Evid Based Complement Alternat Med 2019;2019:5752670. [PMID: 31236125 DOI: 10.1155/2019/5752670] [Reference Citation Analysis]
177 Peng Z, Gong Y, Liang X. Role of FAT1 in health and disease. Oncol Lett 2021;21:398. [PMID: 33777221 DOI: 10.3892/ol.2021.12659] [Reference Citation Analysis]
178 Xiao D, Fang TX, Lei Y, Xiao SJ, Xia JW, Lin TY, Li YL, Zhai JX, Li XY, Huang SH, Jia JS, Tian YG, Lin XL, Cai KC, Sun Y. m6A demethylase ALKBH5 suppression contributes to esophageal squamous cell carcinoma progression. Aging (Albany NY) 2021;13:21497-512. [PMID: 34491904 DOI: 10.18632/aging.203490] [Reference Citation Analysis]
179 Ma Z, Dong Z, Yu D, Mu M, Feng W, Guo J, Cheng B, Guo J, Ma J. IL-32 Promotes the Radiosensitivity of Esophageal Squamous Cell Carcinoma Cell through STAT3 Pathway. Biomed Res Int 2021;2021:6653747. [PMID: 33681363 DOI: 10.1155/2021/6653747] [Reference Citation Analysis]
180 Cui Y, Yang J, Bai Y, Zhang Y, Yao Y, Zheng T, Liu C, Wu F. miR-424-5p regulates cell proliferation and migration of esophageal squamous cell carcinoma by targeting SIRT4. J Cancer 2020;11:6337-47. [PMID: 33033517 DOI: 10.7150/jca.50587] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
181 Tamaoki M, Yokoyama A, Horimatsu T, Hirohashi K, Amanuma Y, Higuchi H, Mitani Y, Yoshioka M, Ohashi S, Muto M. Repeated talaporfin sodium photodynamic therapy for esophageal cancer: safety and efficacy. Esophagus 2021;18:817-24. [PMID: 34106353 DOI: 10.1007/s10388-021-00853-x] [Reference Citation Analysis]
182 Zhang Q, Zhao X, Zhang C, Wang W, Li F, Liu D, Wu K, Zhu D, Liu S, Shen C, Yuan X, Zhang K, Yang Y, Zhang Y, Zhao S. Overexpressed PKMYT1 promotes tumor progression and associates with poor survival in esophageal squamous cell carcinoma. Cancer Manag Res 2019;11:7813-24. [PMID: 31695486 DOI: 10.2147/CMAR.S214243] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
183 Kwak AW, Yoon G, Lee MH, Cho SS, Shim JH, Chae JI. Picropodophyllotoxin, an Epimer of Podophyllotoxin, Causes Apoptosis of Human Esophageal Squamous Cell Carcinoma Cells Through ROS-Mediated JNK/P38 MAPK Pathways. Int J Mol Sci 2020;21:E4640. [PMID: 32629820 DOI: 10.3390/ijms21134640] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
184 Liang Y, Wu Y, Chen X, Zhang S, Wang K, Guan X, Yang K, Li J, Bai Y. A novel long noncoding RNA linc00460 up-regulated by CBP/P300 promotes carcinogenesis in esophageal squamous cell carcinoma. Biosci Rep 2017;37:BSR20171019. [PMID: 28939763 DOI: 10.1042/BSR20171019] [Cited by in Crossref: 46] [Cited by in F6Publishing: 38] [Article Influence: 9.2] [Reference Citation Analysis]
185 Cao Q, Li Y, Li Z, An D, Li B, Lin Q. Development and validation of a radiomics signature on differentially expressed features of 18F-FDG PET to predict treatment response of concurrent chemoradiotherapy in thoracic esophagus squamous cell carcinoma. Radiother Oncol 2020;146:9-15. [PMID: 32065875 DOI: 10.1016/j.radonc.2020.01.027] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
186 Yang Y, Xu H, Zhou L, Deng T, Ning T, Liu R, Zhang L, Wang X, Ge S, Li H, Ba Y. Platelet to lymphocyte ratio is a predictive marker of prognosis and therapeutic effect of postoperative chemotherapy in non-metastatic esophageal squamous cell carcinoma. Clin Chim Acta 2018;479:160-5. [PMID: 29325800 DOI: 10.1016/j.cca.2018.01.013] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
187 Alaouna M, Hull R, Penny C, Dlamini Z. Esophageal cancer genetics in South Africa. Clin Exp Gastroenterol 2019;12:157-77. [PMID: 31114287 DOI: 10.2147/CEG.S182000] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
188 Zhang H, Zhao H, He X, Xi F, Liu J. JAK-STAT Domain Enhanced MUC1-CAR-T Cells Induced Esophageal Cancer Elimination. Cancer Manag Res 2020;12:9813-24. [PMID: 33116840 DOI: 10.2147/CMAR.S264358] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
189 Wang H, Yu J, Guo Y, Zhang Z, Liu G, Li J, Zhang X, Jin T, Wang Z. Genetic variants in the ZNF208 gene are associated with esophageal cancer in a Chinese Han population. Oncotarget 2016;7:86829-35. [PMID: 27907911 DOI: 10.18632/oncotarget.13468] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
190 Lu Z, Zheng S, Liu C, Wang X, Zhang G, Wang F, Wang S, Huang J, Mao S, Lei Y, Wang Z, Sun N, He J. S100A7 as a potential diagnostic and prognostic biomarker of esophageal squamous cell carcinoma promotes M2 macrophage infiltration and angiogenesis. Clin Transl Med 2021;11:e459. [PMID: 34323409 DOI: 10.1002/ctm2.459] [Reference Citation Analysis]
191 Zhang ZF, Huang TJ, Zhang XK, Xie YJ, Lin ST, Luo FF, Meng DF, Hu H, Wang J, Peng LX, Qian CN, Cheng C, Huang BJ. AKR1C2 acts as a targetable oncogene in esophageal squamous cell carcinoma via activating PI3K/AKT signaling pathway. J Cell Mol Med 2020;24:9999-10012. [PMID: 32678482 DOI: 10.1111/jcmm.15604] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
192 Torres-Aguilera M, Remes Troche JM. Achalasia and esophageal cancer: risks and links. Clin Exp Gastroenterol 2018;11:309-16. [PMID: 30233226 DOI: 10.2147/CEG.S141642] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 3.8] [Reference Citation Analysis]
193 Li Y, Zhu X, Yang M, Wang Y, Li J, Fang J, Guo W, Ma S, Guan F. YAP/TEAD4-induced KIF4A contributes to the progression and worse prognosis of esophageal squamous cell carcinoma. Mol Carcinog 2021;60:440-54. [PMID: 34003522 DOI: 10.1002/mc.23303] [Reference Citation Analysis]
194 Ning Z, Zhu X, Jiang Y, Gao A, Zou S, Gu C, He C, Chen Y, Ding WQ, Zhou J. Integrin-Linked Kinase Is Involved In the Proliferation and Invasion of Esophageal Squamous Cell Carcinoma. J Cancer 2020;11:324-33. [PMID: 31897228 DOI: 10.7150/jca.33737] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
195 Cossu AM, Mosca L, Zappavigna S, Misso G, Bocchetti M, De Micco F, Quagliuolo L, Porcelli M, Caraglia M, Boccellino M. Long Non-coding RNAs as Important Biomarkers in Laryngeal Cancer and Other Head and Neck Tumours. Int J Mol Sci 2019;20:E3444. [PMID: 31336999 DOI: 10.3390/ijms20143444] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 10.3] [Reference Citation Analysis]
196 Erkizan HV, Johnson K, Ghimbovschi S, Karkera D, Trachiotis G, Adib H, Hoffman EP, Wadleigh RG. African-American esophageal squamous cell carcinoma expression profile reveals dysregulation of stress response and detox networks. BMC Cancer 2017;17:426. [PMID: 28629367 DOI: 10.1186/s12885-017-3423-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
197 Luchini C, Wood LD, Cheng L, Nottegar A, Stubbs B, Solmi M, Capelli P, Pea A, Sergi G, Manzato E. Extranodal extension of lymph node metastasis is a marker of poor prognosis in oesophageal cancer: a systematic review with meta-analysis. J Clin Pathol. 2016;. [PMID: 27387986 DOI: 10.1136/jclinpath-2016-203830] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
198 Xu F, Zhang S, Liu Z, Gu J, Li Y, Wang L, Mao W, Zhu Q, Shou H, Ge D, Lu C. TEX9 and eIF3b functionally synergize to promote the progression of esophageal squamous cell carcinoma. BMC Cancer 2019;19:875. [PMID: 31481019 DOI: 10.1186/s12885-019-6071-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
199 Zhang J, Luo A, Huang F, Gong T, Liu Z. SERPINE2 promotes esophageal squamous cell carcinoma metastasis by activating BMP4. Cancer Lett 2020;469:390-8. [PMID: 31730904 DOI: 10.1016/j.canlet.2019.11.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
200 Mizumoto A, Ohashi S, Hirohashi K, Amanuma Y, Matsuda T, Muto M. Molecular Mechanisms of Acetaldehyde-Mediated Carcinogenesis in Squamous Epithelium. Int J Mol Sci 2017;18:E1943. [PMID: 28891965 DOI: 10.3390/ijms18091943] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
201 Yoshioka M, Ohashi S, Ida T, Nakai Y, Kikuchi O, Amanuma Y, Matsubara J, Yamada A, Miyamoto S, Natsuizaka M, Nakagawa H, Chiba T, Seno H, Muto M. Distinct effects of EGFR inhibitors on epithelial- and mesenchymal-like esophageal squamous cell carcinoma cells. J Exp Clin Cancer Res 2017;36:101. [PMID: 28764725 DOI: 10.1186/s13046-017-0572-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
202 Zhang Z, Liang X, Ren L, Zhang S, Li S, Wan T, Xu D, Lv S. LINC00662 promotes cell viability and metastasis in esophageal squamous cell carcinoma by sponging miR-340-5p and upregulating HOXB2. Thorac Cancer 2020;11:2306-15. [PMID: 32633082 DOI: 10.1111/1759-7714.13551] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
203 Zhu P, Huang H, Gu S, Liu Z, Zhang X, Wu K, Lu T, Li L, Dong C, Zhong C, Zhou Y. Long Noncoding RNA FAM225A Promotes Esophageal Squamous Cell Carcinoma Development and Progression via Sponging MicroRNA-197-5p and Upregulating NONO. J Cancer 2021;12:1073-84. [PMID: 33442405 DOI: 10.7150/jca.51292] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
204 Wen J, Hu Y, Liu Q, Ling Y, Zhang S, Luo K, Xie X, Fu J, Yang H. miR-424 coordinates multilayered regulation of cell cycle progression to promote esophageal squamous cell carcinoma cell proliferation. EBioMedicine 2018;37:110-24. [PMID: 30361064 DOI: 10.1016/j.ebiom.2018.10.043] [Cited by in Crossref: 18] [Cited by in F6Publishing: 24] [Article Influence: 4.5] [Reference Citation Analysis]
205 Gao X, Liu Q, Chen X, Chen S, Yang J, Liu Q, Cheng Y. Screening of tumor grade-related mRNAs and lncRNAs for Esophagus Squamous Cell Carcinoma. J Clin Lab Anal 2021;35:e23797. [PMID: 33960436 DOI: 10.1002/jcla.23797] [Reference Citation Analysis]
206 Qu J, Ma L, Lu Y, Wang Z, Guo J, Zhang H, Yan X, Liu H, Kamel IR, Qin J, Li H. DCE-MRI radiomics nomogram can predict response to neoadjuvant chemotherapy in esophageal cancer. Discov Onc 2022;13. [DOI: 10.1007/s12672-022-00464-7] [Reference Citation Analysis]
207 Gao Y, Qiu J, Gu L, Yang Y, Kang H, Zhang Y, Zhang S, Zhang Y, Wang H, Zhang Y, Qian J. Secondary primary lung cancer after esophageal cancer: a population-based study of 44,172 patients. Scand J Gastroenterol 2021;:1-10. [PMID: 34726133 DOI: 10.1080/00365521.2021.1994639] [Reference Citation Analysis]
208 Wu Y, Hu L, Liang Y, Li J, Wang K, Chen X, Meng H, Guan X, Yang K, Bai Y. Up-regulation of lncRNA CASC9 promotes esophageal squamous cell carcinoma growth by negatively regulating PDCD4 expression through EZH2. Mol Cancer. 2017;16:150. [PMID: 28854977 DOI: 10.1186/s12943-017-0715-7] [Cited by in Crossref: 78] [Cited by in F6Publishing: 92] [Article Influence: 15.6] [Reference Citation Analysis]
209 Bijlsma MF, Sadanandam A, Tan P, Vermeulen L. Molecular subtypes in cancers of the gastrointestinal tract. Nat Rev Gastroenterol Hepatol 2017;14:333-42. [PMID: 28400627 DOI: 10.1038/nrgastro.2017.33] [Cited by in Crossref: 60] [Cited by in F6Publishing: 54] [Article Influence: 12.0] [Reference Citation Analysis]
210 Luo D, Huang Z, Lv H, Wang Y, Sun W, Sun X. Up-Regulation of MicroRNA-21 Indicates Poor Prognosis and Promotes Cell Proliferation in Esophageal Squamous Cell Carcinoma via Upregulation of lncRNA SNHG1. Cancer Manag Res 2020;12:1-14. [PMID: 32021418 DOI: 10.2147/CMAR.S221731] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
211 Moghadam AR, Mehramiz M, Entezari M, Aboutalebi H, Kohansal F, Dadjoo P, Fiuji H, Nasiri M, Aledavood SA, Anvari K, Simab SA, Khorrami MS, Moradi A, Hassanian SM, Ferns GA, Sales SS, Avan A. A genetic polymorphism in the CYP1B1 gene in patients with squamous cell carcinoma of the esophagus: an Iranian Mashhad cohort study recruited over 10 years. Pharmacogenomics 2018;19:539-46. [DOI: 10.2217/pgs-2018-0197] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
212 Lu T, Chen D, Wang Y, Sun X, Li S, Miao S, Wo Y, Dong Y, Leng X, Du W, Jiao W. Identification of DNA methylation-driven genes in esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas. Cancer Cell Int 2019;19:52. [PMID: 30886542 DOI: 10.1186/s12935-019-0770-9] [Cited by in Crossref: 23] [Cited by in F6Publishing: 30] [Article Influence: 7.7] [Reference Citation Analysis]
213 Hirohashi K, Ohashi S, Amanuma Y, Nakai Y, Ida T, Baba K, Mitani Y, Mizumoto A, Yamamoto Y, Kikuchi O, Matsubara J, Yamada A, Miyamoto S, Seno H, Matsuda T, Muto M. Protective effects of Alda-1, an ALDH2 activator, on alcohol-derived DNA damage in the esophagus of human ALDH2*2 (Glu504Lys) knock-in mice. Carcinogenesis 2020;41:194-202. [PMID: 31074772 DOI: 10.1093/carcin/bgz091] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
214 Wu IC, Syu HY, Jen CP, Lu MY, Chen YT, Wu MT, Kuo CT, Tsai YY, Wang HC. Early identification of esophageal squamous neoplasm by hyperspectral endoscopic imaging. Sci Rep 2018;8:13797. [PMID: 30218087 DOI: 10.1038/s41598-018-32139-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
215 Kigen G, Busakhala N, Kamuren Z, Rono H, Kimalat W, Njiru E. Factors associated with the high prevalence of oesophageal cancer in Western Kenya: a review. Infect Agent Cancer 2017;12:59. [PMID: 29142587 DOI: 10.1186/s13027-017-0169-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
216 Nomoto D, Baba Y, Liu Y, Tsutsuki H, Okadome K, Harada K, Ishimoto T, Iwatsuki M, Iwagami S, Miyamoto Y, Yoshida N, Watanabe M, Moroishi T, Komohara Y, Sawa T, Baba H. Fusobacterium nucleatum promotes esophageal squamous cell carcinoma progression via the NOD1/RIPK2/NF-κB pathway. Cancer Lett 2022:S0304-3835(22)00022-2. [PMID: 35033591 DOI: 10.1016/j.canlet.2022.01.014] [Reference Citation Analysis]
217 Shi P, Sun J, He B, Song H, Li Z, Kong W, Wang J, Wang J, Xue H. Profiles of differentially expressed circRNAs in esophageal and breast cancer. Cancer Manag Res 2018;10:2207-21. [PMID: 30087579 DOI: 10.2147/CMAR.S167863] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
218 Sun H, Cai X, Zhou H, Li X, Du Z, Zou H, Wu J, Xie L, Cheng Y, Xie W, Lu X, Xu L, Chen L, Li E, Wu B. The protein-protein interaction network and clinical significance of heat-shock proteins in esophageal squamous cell carcinoma. Amino Acids 2018;50:685-97. [PMID: 29700654 DOI: 10.1007/s00726-018-2569-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
219 Dias F, Morais M, Teixeira AL, Medeiros R. Involving the microRNA Targetome in Esophageal-Cancer Development and Behavior. Cancers (Basel) 2018;10:E381. [PMID: 30322005 DOI: 10.3390/cancers10100381] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
220 Wang H, Song T, Qiao Y, Sun J. miR-940 inhibits cell proliferation and promotes apoptosis in esophageal squamous cell carcinoma cells and is associated with post-operative prognosis. Exp Ther Med 2020;19:833-40. [PMID: 32010243 DOI: 10.3892/etm.2019.8279] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
221 Xin Z, Song X, Jiang B, Gongsun X, Song L, Qin Q, Wang Q, Shi M, Liu X. Blocking FGFR4 exerts distinct anti-tumorigenic effects in esophageal squamous cell carcinoma. Thorac Cancer 2018;9:1687-98. [PMID: 30267473 DOI: 10.1111/1759-7714.12883] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
222 Sato H, Terai S, Shimamura Y, Tanaka S, Shiwaku H, Minami H, Sato C, Ogawa R, Yokomichi H, Inoue H. Achalasia and esophageal cancer: a large database analysis in Japan. J Gastroenterol 2021;56:360-70. [PMID: 33538893 DOI: 10.1007/s00535-021-01763-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
223 Hou Z, Abudureheman A, Wang L, Hasim A, Ainiwaer J, Zhang H, Niyaz M, Upur H, Sheyhidin I. Expression, prognosis and functional role of Thsd7a in esophageal squamous cell carcinoma of Kazakh patients, Xinjiang. Oncotarget 2017;8:60539-57. [PMID: 28947992 DOI: 10.18632/oncotarget.16966] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
224 Bastami M, Mahmoodzadeh H, Saadatian Z, Daraei A, Zununi Vahed S, Mansoori Y, Nariman-Saleh-Fam Z. Perturbation of miR-146b and relevant inflammatory elements in esophageal carcinoma patients supports an immune downregulatory mechanism. Pathol Res Pract 2021;225:153560. [PMID: 34311393 DOI: 10.1016/j.prp.2021.153560] [Reference Citation Analysis]
225 Quezada-Marín JI, Lam AK, Ochiai A, Odze RD, Washington KM, Fukayama M, Rugge M, Klimstra DS, Nagtegaal ID, Tan PH, Arends MJ, Goldblum JR, Cree IA, Salto-Tellez M. Gastrointestinal tissue-based molecular biomarkers: a practical categorisation based on the 2019 World Health Organization classification of epithelial digestive tumours. Histopathology 2020;77:340-50. [PMID: 32320495 DOI: 10.1111/his.14120] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
226 Jian J, Li S, Liu LZ, Zhen L, Yao L, Gan LH, Huang YQ, Fang N. XPD inhibits cell growth and invasion and enhances chemosensitivity in esophageal squamous cell carcinoma by regulating the PI3K/AKT signaling pathway. Int J Mol Med 2020;46:201-10. [PMID: 32377720 DOI: 10.3892/ijmm.2020.4593] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
227 Yue GG, Li L, Lee JK, Kwok HF, Wong EC, Li M, Fung KP, Yu J, Chan AW, Chiu PW, Lau CB. Multiple modulatory activities of Andrographis paniculata on immune responses and xenograft growth in esophageal cancer preclinical models. Phytomedicine 2019;60:152886. [PMID: 30910259 DOI: 10.1016/j.phymed.2019.152886] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
228 Zhang Y, Chen W, Pan T, Wang H, Zhang Y, Li C. LBX2-AS1 is activated by ZEB1 and promotes the development of esophageal squamous cell carcinoma by interacting with HNRNPC to enhance the stability of ZEB1 and ZEB2 mRNAs. Biochem Biophys Res Commun 2019;511:566-72. [PMID: 30824187 DOI: 10.1016/j.bbrc.2019.02.079] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 8.0] [Reference Citation Analysis]
229 Wang Y, Wang G, Ma Y, Teng J, Wang Y, Cui Y, Dong Y, Shao S, Zhan Q, Liu X. FAT1, a direct transcriptional target of E2F1, suppresses cell proliferation, migration and invasion in esophageal squamous cell carcinoma. Chin J Cancer Res 2019;31:609-19. [PMID: 31564804 DOI: 10.21147/j.issn.1000-9604.2019.04.05] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
230 Chaber-ciopinska A, Kiprian D, Kawecki A, Kaminski M. Surveillance of patients at high-risk of squamous cell esophageal cancer. Best Practice & Research Clinical Gastroenterology 2016;30:893-900. [DOI: 10.1016/j.bpg.2016.10.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
231 Tan P, Petty R. Prognostic RNAs in oesophageal squamous cell carcinoma: small is beautiful. Gut 2017;66:210-1. [PMID: 27633924 DOI: 10.1136/gutjnl-2016-312585] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
232 Chen H, Yao X, Di X, Zhang Y, Zhu H, Liu S, Chen T, Yu D, Sun X. MiR-450a-5p inhibits autophagy and enhances radiosensitivity by targeting dual-specificity phosphatase 10 in esophageal squamous cell carcinoma. Cancer Lett 2020;483:114-26. [PMID: 32014456 DOI: 10.1016/j.canlet.2020.01.037] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
233 Guo X, Wang Y, Zhang H, Qin C, Cheng A, Liu J, Dai X, Wang Z. Identification of the Prognostic Value of Immune-Related Genes in Esophageal Cancer. Front Genet 2020;11:989. [PMID: 32973887 DOI: 10.3389/fgene.2020.00989] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
234 Singhi AD, Arnold CA, Lam-himlin DM, Nikiforova MN, Voltaggio L, Canto MI, Mcgrath KM, Montgomery EA. Targeted next-generation sequencing supports epidermoid metaplasia of the esophagus as a precursor to esophageal squamous neoplasia. Mod Pathol 2017;30:1613-21. [DOI: 10.1038/modpathol.2017.73] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
235 Sakai A, Nakashima Y, Miyashita Y, Ao T, Kimura Y, Shinto E, Oki E, Shimokawa M, Ueno H, Oda Y, Mori M. Histological categorisation of the desmoplastic reaction is a predictor of patient prognosis in oesophageal squamous cell carcinoma. Histopathology 2021;79:219-26. [PMID: 33595141 DOI: 10.1111/his.14357] [Reference Citation Analysis]
236 Kwak AW, Lee MJ, Lee MH, Yoon G, Cho SS, Chae JI, Shim JH. The 3-deoxysappanchalcone induces ROS-mediated apoptosis and cell cycle arrest via JNK/p38 MAPKs signaling pathway in human esophageal cancer cells. Phytomedicine 2021;86:153564. [PMID: 33895649 DOI: 10.1016/j.phymed.2021.153564] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
237 Ana Choi SS, Ko JM, Yu VZ, Ning L, Lung ML. Differentiation-related zinc finger protein 750 suppresses cell growth in esophageal squamous cell carcinoma. Oncol Lett 2021;22:513. [PMID: 33986873 DOI: 10.3892/ol.2021.12774] [Reference Citation Analysis]
238 Chen F, Li H, Wang Y, Gao M, Cheng Y, Liu D, Jia M, Zhang J. Inhibition of allicin in Eca109 and EC9706 cells via G2/M phase arrest and mitochondrial apoptosis pathway. Journal of Functional Foods 2016;25:523-36. [DOI: 10.1016/j.jff.2016.06.027] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
239 Bai Y, Zhang K, Xu R, Liu H, Guan F, Luo H, Chen Y, Li J. Surface Modification of Esophageal Stent Materials by a Drug-Eluting Layer for Better Anti-Restenosis Function. Coatings 2018;8:215. [DOI: 10.3390/coatings8060215] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
240 Enesca A, Yamaguchi Y, Terashima C, Fujishima A, Nakata K, Duta A. Enhanced UV–Vis photocatalytic performance of the CuInS 2 /TiO 2 /SnO 2 hetero-structure for air decontamination. Journal of Catalysis 2017;350:174-81. [DOI: 10.1016/j.jcat.2017.02.015] [Cited by in Crossref: 24] [Article Influence: 4.8] [Reference Citation Analysis]
241 Koizumi S, Motoyama S, Iijima K. Is the incidence of esophageal adenocarcinoma increasing in Japan? Trends from the data of a hospital-based registration system in Akita Prefecture, Japan. J Gastroenterol 2018;53:827-33. [PMID: 29134330 DOI: 10.1007/s00535-017-1412-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
242 Yang Y, Huang X, Zhou L, Deng T, Ning T, Liu R, Zhang L, Bai M, Zhang H, Li H, Ba Y. Clinical use of tumor biomarkers in prediction for prognosis and chemotherapeutic effect in esophageal squamous cell carcinoma. BMC Cancer 2019;19:526. [PMID: 31151431 DOI: 10.1186/s12885-019-5755-5] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 5.7] [Reference Citation Analysis]
243 Song G, Liu K, Zhu X, Yang X, Shen Y, Wang W, Shi G, Li Q, Duan Y, Zhao Y, Feng G. The low IGFBP-3 level is associated with esophageal cancer patients: a meta-analysis. World J Surg Oncol 2016;14:307. [PMID: 27978831 DOI: 10.1186/s12957-016-1055-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
244 Lv X, Li Y, Li Y, Li H, Zhou L, Wang B, Zhi Z, Tang W. FAL1: A critical oncogenic long non-coding RNA in human cancers. Life Sci 2019;236:116918. [PMID: 31610208 DOI: 10.1016/j.lfs.2019.116918] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
245 Han L, Dai S, Li Z, Zhang C, Wei S, Zhao R, Zhang H, Zhao L, Shan B. Combination of the natural compound Periplocin and TRAIL induce esophageal squamous cell carcinoma apoptosis in vitro and in vivo: Implication in anticancer therapy. J Exp Clin Cancer Res 2019;38:501. [PMID: 31864387 DOI: 10.1186/s13046-019-1498-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
246 Gao G, Sun B, Wang X, Wang S. Neutrophil to Lymphocyte Ratio as Prognostic Indicator for Patients with Esophageal Squamous Cell Cancer. Int J Biol Markers 2017;32:409-14. [DOI: 10.5301/ijbm.5000294] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
247 Yang CS, Chen XL. Research on esophageal cancer: With personal perspectives from studies in China and Kenya. Int J Cancer 2021;149:264-76. [PMID: 33270917 DOI: 10.1002/ijc.33421] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
248 Hernandez-Castillo C, Termini J, Shuck S. DNA Adducts as Biomarkers To Predict, Prevent, and Diagnose Disease-Application of Analytical Chemistry to Clinical Investigations. Chem Res Toxicol 2020;33:286-307. [PMID: 31638384 DOI: 10.1021/acs.chemrestox.9b00295] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
249 Zhang B, Zhang C, Yang X, Chen Y, Zhang H, Liu J, Wu Q. Cytoplasmic collagen XIαI as a prognostic biomarker in esophageal squamous cell carcinoma. Cancer Biol Ther 2018;19:364-72. [PMID: 29333916 DOI: 10.1080/15384047.2018.1423915] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
250 Zhang Y, Luo Z, Yang L, Chen S, Chen C, Lin Z. The association between four SNPs of X-ray repair cross complementing protein 1 and the sensitivity to radiotherapy in patients with esophageal squamous cell carcinoma. Oncol Lett 2016;11:3508-14. [PMID: 27123143 DOI: 10.3892/ol.2016.4384] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
251 Zhan XH, Jiao JW, Zhang HF, Li CQ, Zhao JM, Liao LD, Wu JY, Wu BL, Wu ZY, Wang SH, Du ZP, Shen JH, Zou HY, Neufeld G, Xu LY, Li EM. A three-gene signature from protein-protein interaction network of LOXL2- and actin-related proteins for esophageal squamous cell carcinoma prognosis. Cancer Med 2017;6:1707-19. [PMID: 28556501 DOI: 10.1002/cam4.1096] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
252 Ferndale L, Aldous C, Hift R, Thomson S. Gender Differences in Oesophageal Squamous Cell Carcinoma in a South African Tertiary Hospital. Int J Environ Res Public Health 2020;17:E7086. [PMID: 32998198 DOI: 10.3390/ijerph17197086] [Reference Citation Analysis]
253 Lu Z, Lu C, Li C, Jiao Y, Li Y, Zhang G. Dracorhodin perchlorate induces apoptosis and G2/M cell cycle arrest in human esophageal squamous cell carcinoma through inhibition of the JAK2/STAT3 and AKT/FOXO3a pathways. Mol Med Rep 2019;20:2091-100. [PMID: 31322237 DOI: 10.3892/mmr.2019.10474] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
254 Li J, Li M, Gao F, Ge X. Serum microRNA-15a level acts as a potential diagnostic and prognostic biomarker for human esophageal squamous cell carcinoma. Cancer Biomark 2017;18:11-7. [PMID: 27802201 DOI: 10.3233/CBM-160667] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 2.4] [Reference Citation Analysis]
255 Moore M, Sharma P. Updates in artificial intelligence in gastroenterology endoscopy in 2020. Curr Opin Gastroenterol 2021;37:428-33. [PMID: 34387253 DOI: 10.1097/MOG.0000000000000774] [Reference Citation Analysis]
256 Wang X, Wang J, Jia Y, Wang Y, Han X, Duan Y, Lv W, Ma M, Liu L. Methylation decreases the Bin1 tumor suppressor in ESCC and restoration by decitabine inhibits the epithelial mesenchymal transition. Oncotarget 2017;8:19661-73. [PMID: 28152502 DOI: 10.18632/oncotarget.14914] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
257 Ashktorab H, Kupfer SS, Brim H, Carethers JM. Racial Disparity in Gastrointestinal Cancer Risk. Gastroenterology. 2017;153:910-923. [PMID: 28807841 DOI: 10.1053/j.gastro.2017.08.018] [Cited by in Crossref: 99] [Cited by in F6Publishing: 98] [Article Influence: 19.8] [Reference Citation Analysis]
258 Hu Y, Teng X, Wu L, Liu W, An J. The Clinicopathological Correlations of hTERC Amplification with Esophageal Squamous Cell Precursor Lesions. Dig Dis Sci 2019;64:68-75. [PMID: 30311151 DOI: 10.1007/s10620-018-5318-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
259 Tripathi M, Swanson PE. Rare tumors of esophageal squamous mucosa. Ann N Y Acad Sci 2016;1381:122-32. [PMID: 27310830 DOI: 10.1111/nyas.13108] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
260 Xu B, Chen H, Xu Z, Yao X, Sun X, Cheng H. CDCA2 promotes tumorigenesis and induces radioresistance in oesophageal squamous cell carcinoma cells. Mol Med Rep 2021;24:530. [PMID: 34036376 DOI: 10.3892/mmr.2021.12169] [Reference Citation Analysis]
261 Wen J, Pang Y, Zhou T, Qi X, Zhao M, Xuan B, Meng X, Guo Y, Liu Q, Liang H, Li Y, Dong H, Wang Y. Essential role of Na+/Ca2+ exchanger 1 in smoking-induced growth and migration of esophageal squamous cell carcinoma. Oncotarget. 2016;7:63816-63828. [PMID: 27588478 DOI: 10.18632/oncotarget.11695] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
262 Wang Q, Xie S, Li W, Lagergren J. Smoking Cessation and Risk of Esophageal Cancer by Histological Type: Systematic Review and Meta-analysis. JNCI: Journal of the National Cancer Institute 2017;109. [DOI: 10.1093/jnci/djx115] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 4.2] [Reference Citation Analysis]
263 Faccin TC, Masuda EK, Piazer JVM, Melo SMP, Kommers GD. Annular Stenotic Oesophageal Squamous Cell Carcinoma in Cattle Exposed Naturally to Bracken Fern (Pteridium arachnoideum). J Comp Pathol 2017;157:174-80. [PMID: 28942300 DOI: 10.1016/j.jcpa.2017.07.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
264 Song W, Wang H, Tian Y, Liu S, Chen X, Cui J, Zhao Y. Refractory solitary cervical lymph node metastasis after esophageal squamous cell carcinoma surgery and its successful treatment with immune checkpoint inhibitor: A case report and literature review. Medicine (Baltimore) 2020;99:e19440. [PMID: 32150096 DOI: 10.1097/MD.0000000000019440] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]